Shah MA - Search Results

1

Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update.

Sohal DPS, Kennedy EB, Khorana A, Copur MS, Crane CH, Garrido-Laguna I, Krishnamurthi S, Moravek C, O'Reilly EM, Philip PA, Ramanathan RK, Ruggiero JT, Shah MA, Urba S, Uronis HE, Lau MW, Laheru D. Sohal DPS, et al. Among authors: shah ma. J Clin Oncol. 2018 Aug 20;36(24):2545-2556. doi: 10.1200/JCO.2018.78.9636. Epub 2018 May 23. J Clin Oncol. 2018. PMID: 29791286 Free PMC article.

2

Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.

Shah MA, Schwartz GK. Shah MA, et al. Clin Cancer Res. 2001 Aug;7(8):2168-81. Clin Cancer Res. 2001. PMID: 11489790 Review.

3

Treatment of metastatic esophagus and gastric cancer.

Shah MA, Schwartz GK. Shah MA, et al. Semin Oncol. 2004 Aug;31(4):574-87. doi: 10.1053/j.seminoncol.2004.04.013. Semin Oncol. 2004. PMID: 15297948 Review.

4

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

Chung KY, Shia J, Kemeny NE, Shah M, Schwartz GK, Tse A, Hamilton A, Pan D, Schrag D, Schwartz L, Klimstra DS, Fridman D, Kelsen DP, Saltz LB. Chung KY, et al. J Clin Oncol. 2005 Mar 20;23(9):1803-10. doi: 10.1200/JCO.2005.08.037. Epub 2005 Jan 27. J Clin Oncol. 2005. PMID: 15677699

5

Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors.

Kortmansky J, Shah MA, Kaubisch A, Weyerbacher A, Yi S, Tong W, Sowers R, Gonen M, O'reilly E, Kemeny N, Ilson DI, Saltz LB, Maki RG, Kelsen DP, Schwartz GK. Kortmansky J, et al. Among authors: shah ma. J Clin Oncol. 2005 Mar 20;23(9):1875-84. doi: 10.1200/JCO.2005.03.116. Epub 2005 Feb 7. J Clin Oncol. 2005. PMID: 15699481 Clinical Trial.

6

A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol.

Shah MA, Kortmansky J, Motwani M, Drobnjak M, Gonen M, Yi S, Weyerbacher A, Cordon-Cardo C, Lefkowitz R, Brenner B, O'Reilly E, Saltz L, Tong W, Kelsen DP, Schwartz GK. Shah MA, et al. Clin Cancer Res. 2005 May 15;11(10):3836-45. doi: 10.1158/1078-0432.CCR-04-2651. Clin Cancer Res. 2005. PMID: 15897584 Clinical Trial.

7

Gastric cancer: an update.

Shah MA. Shah MA. Curr Oncol Rep. 2006 May;8(3):183-91. doi: 10.1007/s11912-006-0018-4. Curr Oncol Rep. 2006. PMID: 16618382 Review.

8

A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer.

Brenner B, Shah MA, Karpeh MS, Gonen M, Brennan MF, Coit DG, Klimstra DS, Tang LH, Kelsen DP. Brenner B, et al. Among authors: shah ma. Ann Oncol. 2006 Sep;17(9):1404-11. doi: 10.1093/annonc/mdl133. Epub 2006 Jun 20. Ann Oncol. 2006. PMID: 16788003 Free article. Clinical Trial.

9

Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma.

Shah MA, Ramanathan RK, Ilson DH, Levnor A, D'Adamo D, O'Reilly E, Tse A, Trocola R, Schwartz L, Capanu M, Schwartz GK, Kelsen DP. Shah MA, et al. J Clin Oncol. 2006 Nov 20;24(33):5201-6. doi: 10.1200/JCO.2006.08.0887. J Clin Oncol. 2006. PMID: 17114652 Clinical Trial.

10

Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors.

Fornier MN, Rathkopf D, Shah M, Patil S, O'Reilly E, Tse AN, Hudis C, Lefkowitz R, Kelsen DP, Schwartz GK. Fornier MN, et al. Clin Cancer Res. 2007 Oct 1;13(19):5841-6. doi: 10.1158/1078-0432.CCR-07-1218. Clin Cancer Res. 2007. PMID: 17908977 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,048 results

Search Page